Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
09 04 2021
Historique:
received: 23 12 2020
accepted: 26 02 2021
pubmed: 5 3 2021
medline: 24 4 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, VOC 202012/01 (lineage B.1.1.7), emerged in southeast England in September 2020 and is rapidly spreading toward fixation. Using a variety of statistical and dynamic modeling approaches, we estimate that this variant has a 43 to 90% (range of 95% credible intervals, 38 to 130%) higher reproduction number than preexisting variants. A fitted two-strain dynamic transmission model shows that VOC 202012/01 will lead to large resurgences of COVID-19 cases. Without stringent control measures, including limited closure of educational institutions and a greatly accelerated vaccine rollout, COVID-19 hospitalizations and deaths across England in the first 6 months of 2021 were projected to exceed those in 2020. VOC 202012/01 has spread globally and exhibits a similar transmission increase (59 to 74%) in Denmark, Switzerland, and the United States.

Identifiants

pubmed: 33658326
pii: science.abg3055
doi: 10.1126/science.abg3055
pmc: PMC8128288
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 206250/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19027
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19065
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S017968/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Q Rev Biol. 1996 Mar;71(1):37-78
pubmed: 8919665
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Nat Commun. 2019 Jun 20;10(1):2719
pubmed: 31222023
BMJ. 2021 Feb 1;372:n296
pubmed: 33526412
Genetics. 1996 May;143(1):15-26
pubmed: 8722758
Cell. 2021 Mar 4;184(5):1171-1187.e20
pubmed: 33621484
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Eur J Epidemiol. 2020 Dec;35(12):1123-1138
pubmed: 33289900
Cell. 2021 May 13;184(10):2587-2594.e7
pubmed: 33861950
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
Nature. 2021 Apr;592(7853):277-282
pubmed: 33545711
Philos Trans R Soc Lond B Biol Sci. 2019 Sep 30;374(1782):20180331
pubmed: 31401950
Ecol Lett. 2007 Oct;10(10):876-88
pubmed: 17845288
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Euro Surveill. 2020 Apr;25(17):
pubmed: 32372755
Proc Biol Sci. 2007 Feb 22;274(1609):599-604
pubmed: 17476782
Biol Lett. 2011 Apr 23;7(2):210-3
pubmed: 20810425
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
BMC Med. 2020 May 7;18(1):124
pubmed: 32375776
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Int J Infect Dis. 2020 Apr;93:284-286
pubmed: 32145466
Science. 2020 Sep 25;369(6511):1603-1607
pubmed: 32732280
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Epidemics. 2011 Jun;3(2):103-8
pubmed: 21624781
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
Lancet Public Health. 2020 Jul;5(7):e375-e385
pubmed: 32502389
Lancet Infect Dis. 2021 Apr;21(4):482-492
pubmed: 33357518
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Wellcome Open Res. 2021 May 19;6:121
pubmed: 34095513
J R Soc Interface. 2020 Jul;17(168):20200144
pubmed: 32693748
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
PLoS Med. 2008 Mar 25;5(3):e74
pubmed: 18366252

Auteurs

Nicholas G Davies (NG)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK. nicholas.davies@lshtm.ac.uk.

Sam Abbott (S)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Rosanna C Barnard (RC)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Christopher I Jarvis (CI)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Adam J Kucharski (AJ)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

James D Munday (JD)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Carl A B Pearson (CAB)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Timothy W Russell (TW)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Damien C Tully (DC)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Alex D Washburne (AD)

Selva Analytics LLC, Bozeman, MT, USA.

Tom Wenseleers (T)

Lab of Socioecology and Social Evolution, KU Leuven, Leuven, Belgium.

Amy Gimma (A)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

William Waites (W)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Kerry L M Wong (KLM)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Kevin van Zandvoort (K)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Justin D Silverman (JD)

College of Information Science and Technology, Pennsylvania State University, University Park, PA, USA.

Karla Diaz-Ordaz (K)

Centre for Statistical Methodology and Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

Ruth Keogh (R)

Centre for Statistical Methodology and Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

Rosalind M Eggo (RM)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Sebastian Funk (S)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Mark Jit (M)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Katherine E Atkins (KE)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Centre for Global Health, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

W John Edmunds (WJ)

Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH